Takeda Becomes the Latest to Notch an Alzheimer's Failure Under Its Belt
Another experimental Alzheimer's disease treatment has failed in a late-stage study. Source: BioSpace
Another experimental Alzheimer's disease treatment has failed in a late-stage study. Source: BioSpace
The effort was announced last week by the Henri A. Termeer Tribute Committee. Source: BioSpace
Immune-Onc Therapeutics launched in September 2016 and is headquartered in Palo Alto, California. Source: BioSpace
Lilly finally revealed the data in the New England Journal of Medicine. Source: BioSpace
After a brief stumble with UCART123 that resulted in a clinical hold last year, Cellectis is moving on with its study. Source: BioSpace
Could Cara be the answer for investors itching to make $1 million? Source: BioSpace
But for now, the world’s biggest healthcare company isn’t providing many details on how it may use the extra money from lower tax rates. Source: BioSpace
Significant risk remains for companies that cannot move quickly enough to positively impact R&D productivity and for those that encounter challenges in accessing technology and expertise that likely lie outside…
Novo has tried to apply pressure, but the ABLX board and principal shareholder have not been moved. Source: BioSpace
Headquartered in South San Francisco, Surrozen focuses on developing drugs by leveraging insights into the Wnt signaling pathway. Source: BioSpace